BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheen AJ. Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies. Diabetes Metab 2020;47:101220. [PMID: 33359486 DOI: 10.1016/j.diabet.2020.101220] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Divita M, Chonde M, Kamath M, Vucicevic D, Fan AM, Baas AS, Hsu JJ. COVID‐19: Cardiology Perspective. Coronavirus Disease 2019 (COVID‐19) 2023. [DOI: 10.1002/9781119789741.ch16] [Reference Citation Analysis]
2 Ageev AA, Kozhevnikova MV, Emelyanov AV, Krivova AV, Shumskaya YF, Musaeva LM, Popova LV, Naymann YI, Abdullaeva GB, Privalova EV, Belenkov YN. The Effect of COVID-19 on Long-Term Cardiac Function in Patients With Chronic Heart Failure. Kardiologiia 2022;62:23-9. [PMID: 36636973 DOI: 10.18087/cardio.2022.12.n2265] [Reference Citation Analysis]
3 Antonazzo IC, Fornari C, Rozza D, Conti S, Di Pasquale R, Cortesi PA, Kaleci S, Ferrara P, Zucchi A, Maifredi G, Silenzi A, Cesana G, Mantovani LG, Mazzaglia G. Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study. J Clin Med 2022;11. [PMID: 36556112 DOI: 10.3390/jcm11247492] [Reference Citation Analysis]
4 Lao US, Law CF, Baptista-Hon DT, Tomlinson B. Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients. J Clin Med 2022;11:5454. [PMID: 36143101 DOI: 10.3390/jcm11185454] [Reference Citation Analysis]
5 Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm (2020) 2022;3:e157. [PMID: 35958432 DOI: 10.1002/mco2.157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Al Harbi S, Al Shaya A, Badreldin HA, Kensara R, Alharthi AF, Alghamdi J, Alawad A, Alotaibi R, Kharbosh A, Al Muqati H, Alhuwahmel A, Almusallam M, Albarrak G, Al Sulaihim I, Alanazi B, Al-Dosari BS, Vishwakarma R, Alsaeedi AS, Al Ghamdi G, Alkofide H, Al-Dorzi HM. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study. Front Public Health 2022;10:877944. [PMID: 36033795 DOI: 10.3389/fpubh.2022.877944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ghati N, Bhatnagar S, Mahendran M, Thakur A, Prasad K, Kumar D, Dwivedi T, Mani K, Tiwari P, Gupta R, Mohan A, Saxena A, Guleria R, Deepti S. Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial). BMC Infect Dis 2022;22:606. [PMID: 35810307 DOI: 10.1186/s12879-022-07570-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Andaluz-Ojeda D, Vidal-Cortes P, Aparisi Sanz Á, Suberviola B, Del Río Carbajo L, Nogales Martín L, Prol Silva E, Nieto del Olmo J, Barberán J, Cusacovich I. Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review. World J Crit Care Med 2022; 11(4): 269-297 [DOI: 10.5492/wjccm.v11.i4.269] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Umakanthan S, Senthil S, John S, Madhavan MK, Das J, Patil S, Rameshwaram R, Cintham A, Subramaniam V, Yogi M, Bansal A, Achutham S, Shekar C, Murthy V, Selvaraj R. The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study. Front Pharmacol 2022;13:742273. [DOI: 10.3389/fphar.2022.742273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE. High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 2022. [PMID: 35471628 DOI: 10.1007/s10787-022-00988-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
11 Rasmi Y, Heidari N, Kübra Kırboğa K, Hatamkhani S, Tekin B, Alipour S, Naderi R, Farnamian Y, Akca I. The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity. Clin Biochem 2022;104:1-12. [PMID: 35307400 DOI: 10.1016/j.clinbiochem.2022.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Smati S, Tramunt B, Wargny M, Gourdy P, Hadjadj S, Cariou B. COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study. Curr Diab Rep 2022. [PMID: 35171448 DOI: 10.1007/s11892-022-01452-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Andrews L, Goldin L, Shen Y, Korwek K, Kleja K, Poland RE, Guy J, Sands KE, Perlin JB. Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients. Journal of Hospital Medicine. [DOI: 10.1002/jhm.12789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lewek J, Surma S, Banach M. Statins and COVID-19 (Mechanism of Action, Effect on Prognosis). Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_17] [Reference Citation Analysis]
15 Caldara R, Maffi P, Costa S, Bazzigaluppi E, Brigatti C, Lampasona V, Magistretti P, Manenti F, Marzinotto I, Pellegrini S, Scavini M, Secchi A, Piemonti L. COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity. Biology 2021;10:1349. [DOI: 10.3390/biology10121349] [Reference Citation Analysis]
16 Torres-Peña JD, Katsiki N, Perez-Martinez P. Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)? Front Cardiovasc Med 2021;8:775749. [PMID: 34778421 DOI: 10.3389/fcvm.2021.775749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Surma S, Banach M, Lewek J. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection. Lipids Health Dis 2021;20:141. [PMID: 34689776 DOI: 10.1186/s12944-021-01563-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Bergqvist R, Ahlqvist VH, Lundberg M, Hergens MP, Sundström J, Bell M, Magnusson C. HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study. PLoS Med 2021;18:e1003820. [PMID: 34648516 DOI: 10.1371/journal.pmed.1003820] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
19 Battistoni A, Volpe M. Repurposing Cardio-Metabolic Drugs to Fight Covid19. High Blood Press Cardiovasc Prev 2021;28:419-23. [PMID: 34524680 DOI: 10.1007/s40292-021-00475-5] [Reference Citation Analysis]
20 Byttebier G, Belmans L, Alexander M, Saxberg BEH, De Spiegeleer B, De Spiegeleer A, Devreker N, Van Praet JT, Vanhove K, Reybrouck R, Wynendaele E, Fedson DS. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Hum Vaccin Immunother 2021;17:2841-50. [PMID: 34047686 DOI: 10.1080/21645515.2021.1920271] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
21 Minushkina LO, Zateyshchikov DA. Pitavastatin: focus on safety and drug interactions. CardioSomatics 2021;12:48-53. [DOI: 10.26442/22217185.2021.1.200634] [Reference Citation Analysis]
22 Alves M, Fernandes MA, Bahat G, Benetos A, Clemente H, Grodzicki T, Martínez-Sellés M, Mattace-Raso F, Rajkumar C, Ungar A, Werner N, Strandberg TE; EuGMS Special Interest Group inCardiovascular Medicine (Chairpersons A. Ungar and A. Benetos). Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications. Eur Geriatr Med 2021;12:725-39. [PMID: 34031865 DOI: 10.1007/s41999-021-00504-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Byttebier G, Belmans L, Alexander M, Saxberg BE, De Spiegeleer B, De Spiegeleer A, Devrecker N, Van Praet JT, Vanhove K, Reybrouck R, Wynendaele E, Fedson DS. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.. [DOI: 10.1101/2021.03.24.21252687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Nawata K. Estimation of Diabetes Prevalence, and Evaluation of Factors Affecting Blood Glucose Levels and Use of Medications in Japan. Health 2021;13:1431-1451. [DOI: 10.4236/health.2021.1312102] [Reference Citation Analysis]